Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Central Nervous System Neoplasms 11Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Ovarian Neoplasms 3Lung Neoplasms 3Head and Neck Neoplasms 3Gliosarcoma 3Glioblastoma 3Endometrial Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Astrocytoma 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neuroblastoma 2Kidney Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Vomiting 1Urinary Bladder Neoplasms 1Tongue Neoplasms 1Teratoma 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Solitary Fibrous Tumor, Pleural 1Sarcoma, Synovial 1Sarcoma, Endometrial Stromal 1

Interventions

Gemcitabine 18Cisplatin 14Paclitaxel 9Vinblastine 7Methotrexate 7Radiotherapy 6Doxorubicin 6Carboplatin 6Fluorouracil 4Surgical Procedures, Operative 3Mitomycin 3Filgrastim 3BCG Vaccine 3Gefitinib 2Docetaxel 2Cystectomy 2valrubicin 1rubitecan 1romidepsin 1piritrexim 1merphos 1lonafarnib 1durvalumab 1avelumab 1atezolizumab 1Watchful Waiting 1Urination 1Transurethral Resection of Bladder 1Taxes 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Urinary Bladder Neoplasms × Chemotherapy, Adjuvant × Clear all
NCT00023842 2012-09-24

BCG With or Without Mitomycin in Treating Patients With Bladder Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
97 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡